Acquisition of a new flow cytometer for advanced cellular analysis
Official title: CytoFLEX LX flow cytometer
Funded at Johns Hopkins University · NIH-10854278 · Data updated 2026-11-12
This study is about getting a new, advanced machine to help scientists at Johns Hopkins University better understand diseases like Alzheimer's and cancer by analyzing cells more effectively, which means they can gather important information with fewer experiments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $353,235 |
| NIH project number | 1S10OD036395-01 |
| Project ID | NIH-10854278 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals diagnosed with Alzheimer's disease or cancer.
✕Less likely to help
Patients with conditions unrelated to cellular analysis or those not diagnosed with Alzheimer's disease or cancer may not receive benefits from this research.
What this research studies
This research involves the purchase of a state-of-the-art CytoFLEX LX flow cytometer to enhance cellular analysis capabilities at Johns Hopkins University. The new instrument will replace an outdated model and will allow for more experimental modalities, including the ability to measure smaller particles and analyze multiple parameters simultaneously. This advancement will support various ongoing research projects, including those focused on Alzheimer's disease progression and cancer treatment, ultimately leading to better data and insights from fewer experiments.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for conditions like Alzheimer's disease and cancer.
How similar studies have gone: Previous research utilizing advanced flow cytometry techniques has shown promising results in understanding complex cellular interactions and disease mechanisms.
Where this research is happening
-
Johns Hopkins University
Baltimore, United States Active
Researchers
- Principal investigator: Dobbie, Ian Michael — Johns Hopkins University
- Study coordinator: Dobbie, Ian Michael
Related research
Other NIH-funded projects on the same topics.
-
Targeting hidden brain injuries in iTTP to improve long-term brain health
A researcher aims to find out how silent brain injuries in people with immune thrombotic thrombocytopenic purpura (iTTP) happen, how they affect thinking and stroke risk, and how to prevent them.
-
Accelerated flap coverage for severe leg injuries: earlier reconstruction vs standard timing
This study tests whether doing early flap coverage after a severe leg injury lowers infection risk and improves healing for patients with open wounds and bone injury.
-
Placebo-controlled shunting for iNPH: does the surgery help with walking and balance?
A doctor-led trial at Johns Hopkins will test whether a shunt surgery improves walking and balance in older adults with idiopathic normal pressure hydrocephalus.
-
Omalizumab for COPD patients with allergen sensitization and exposure
A multicenter trial will test whether adding omalizumab helps people with COPD who are allergic to common indoor allergens and are exposed to them.
-
Johns Hopkins Total Worker Health Center focusing on mental health
A nationwide center at Johns Hopkins is working to improve mental health and well-being among workers by studying workplace health strategies and translating findings into practical tools.
-
Role of fat droplets in liver fat and inflammatory signals in NAFLD
A study at Johns Hopkins will explore how fat droplets in the liver influence molecules that drive inflammation and progression of non-alcoholic fatty liver disease (NAFLD) in adults.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.